PLOD1 and central nervous system cancer: In conclusion, this study indicated that targeting PLOD1 is a potential therapeutic strategy for glioma patients, and the expression level of PLOD1 may provide a reference for the selection of treatment regimens for glioma patients, which suggests that the biological functions and mechanisms of PLOD1 need to be explored in the future.